Dipyridamole (Avera McKennan Hospital)
Welcome to the PulseAid listing for the Dipyridamole drug offered from Avera McKennan Hospital. This Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Avera McKennan Hospital |
NON-PROPRIETARY NAME: | Dipyridamole |
SUBSTANCE NAME: | DIPYRIDAMOLE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
START MARKETING DATE: | 2015-10-28 |
END MARKETING DATE: | 0000-00-00 |
Dipyridamole HUMAN PRESCRIPTION DRUG Details:
Item Description | Dipyridamole from Avera McKennan Hospital |
LABELER NAME: | Avera McKennan Hospital |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 75(mg/1) |
START MARKETING DATE: | 2015-10-28 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69189-0436_fca40964-5739-4215-9cce-224d10456aea |
PRODUCT NDC: | 69189-0436 |
APPLICATION NUMBER: | NDA012836 |
Other DIPYRIDAMOLE Pharmaceutical Manufacturers / Labelers: